AZD9291
Healthy Volunteer
AstraZenecaSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Healthy Volunteer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Itraconazole Sanofi | Phase 1 | CC |
Ivacaftor Qanatpharma Canada LTD | Phase 1 | CC |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE National Institute of Mental Health (NIMH) | Phase 1 | CC |
ORSYTHIA COMPONENT ETHINYL ESTRADIOL AbbVie | Phase 1 | CC |
Levonorgestrel AbbVie | Phase 1 | CC |
Same molecule, other indications
AZD9291 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →